FLT1 and plasma cell myeloma: Vincent et al. [16] reported that a monoclonal antibody against VEGFR1 inhibited the proliferation and migration of primary multiple myeloma cells via plasma membrane retention of VEGFR1 following the prevention of its nuclear translocation.